Hypertension and Organ Damage in Women
- PMID: 29943358
- DOI: 10.1007/s40292-018-0265-0
Hypertension and Organ Damage in Women
Abstract
An adequate cardiovascular (CV) prevention strategy in women should consider the acknowledgement of sex-specific risk factors, such as hypertension in pregnancy, the concomitant presence of autoimmune diseases and the benefit of evaluating subclinical organ damage and treating hypertension. In accordance to current guidelines, the diagnostic approach does not differ between men and women, although the cardiac response to pressure overload may suggest greater sensitivity in women, and may vary according to age, ethnic background and obesity, that potentiates the effect of hypertension on left ventricular (LV) hypertrophy. Several studies have observed peculiar abnormalities in LV systolic and diastolic function according to gender. The possible mechanisms that influence a different cardiac adaptation to chronic pressure overload in men and women are not fully understood, although hormonal status, and in particular the lack of estrogen effects after menopause may contribute to the cardiovascular adaptation response to increased afterload. The increase in LV mass in response to chronic pressure overload is associated with higher LV ejection fraction in women than in men and LV torsion is maintained with aging in women but not in men. Interstitial fibrosis may reduce circumferential shortening and early diastolic strain rate, in the presence of a preserved ejection fraction in women, favoring the development of heart failure with preserved ejection fraction. Changes in aortic stiffness with aging may influence cardiac structural and functional changes. Isolated systolic hypertension reflects an increase in aortic stiffness, is frequent in women and may be associated to a greater development of concentric LVH. The regression of hypertensive LVH is more difficult in women, and residual hypertrophy is more common in women than in men despite effective antihypertensive treatment and blood pressure control. Carotid atherosclerosis has been extensively investigated in men and women, showing that women usually develop carotid plaques after menopause, with smaller and less unstable plaques; however large and/or a hypoechogenic plaques are more strictly related to cerebrovascular events in women than in men. More advanced abnormalities in the subcutaneous microcirculation have been recently observed, and well translate in the evidence of more prevalent coronary microcirculation involvement in women ischemic heart disease. The prevalence of albuminuria and of reduced estimated glomerular filtration rate (eGFR < 60 ml/min/1.73) are respectively lower and higher in postmenopausal women than in men. Experimental data suggest the possible involvement of renin-angiotensin-aldosterone system and of T regulatory lymphocytes to this regard.
Keywords: Albuminuria; Aortic stiffness; Chronic kidney disease; Left ventricular hypertrophy; Small arteries; Target organ damage; Women.
Similar articles
-
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.Clin J Am Soc Nephrol. 2016 Feb 5;11(2):271-9. doi: 10.2215/CJN.06980615. Epub 2015 Dec 14. Clin J Am Soc Nephrol. 2016. PMID: 26668021 Free PMC article.
-
Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients.J Hum Hypertens. 2007 Apr;21(4):291-6. doi: 10.1038/sj.jhh.1002145. Epub 2007 Jan 25. J Hum Hypertens. 2007. PMID: 17252030
-
Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F309-19. doi: 10.1152/ajprenal.00129.2014. Epub 2014 Dec 10. Am J Physiol Renal Physiol. 2015. PMID: 25503724 Free PMC article.
-
Left ventricular hypertrophy and heart failure in women.J Hypertens Suppl. 2002 May;20(2):S34-8. J Hypertens Suppl. 2002. PMID: 12183849 Review.
-
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Adv Exp Med Biol. 2017. PMID: 27873229 Review.
Cited by
-
Should women have lower thresholds for hypertension diagnosis and treatment?J Hum Hypertens. 2023 Aug;37(8):753-754. doi: 10.1038/s41371-023-00838-6. Epub 2023 May 11. J Hum Hypertens. 2023. PMID: 37169969 No abstract available.
-
Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophy.J Clin Hypertens (Greenwich). 2021 May;23(5):1008-1016. doi: 10.1111/jch.14206. Epub 2021 Mar 10. J Clin Hypertens (Greenwich). 2021. PMID: 33694311 Free PMC article. Clinical Trial.
-
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies.Curr Heart Fail Rep. 2023 Feb;20(1):56-62. doi: 10.1007/s11897-023-00590-5. Epub 2023 Jan 25. Curr Heart Fail Rep. 2023. PMID: 36696001 Free PMC article. Review.
-
The strain and strain rate imaging paradox in echocardiography: overabundant literature in the last two decades but still uncertain clinical utility in an individual case.Arch Med Sci Atheroscler Dis. 2020 Dec 26;5:e297-e305. doi: 10.5114/amsad.2020.103032. eCollection 2020. Arch Med Sci Atheroscler Dis. 2020. PMID: 33644489 Free PMC article.
-
Position Statement on Women's Cardiovascular Health - 2022.Arq Bras Cardiol. 2022 Nov;119(5):815-882. doi: 10.36660/abc.20220734. Arq Bras Cardiol. 2022. PMID: 36453774 Free PMC article. English, Portuguese. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous